SLC12A6 Gene Agenesis of the Corpus Callosum with Peripheral Neuropathy NGS Genetic DNA Test
Introduction
The SLC12A6 Gene Agenesis of the Corpus Callosum with Peripheral Neuropathy NGS Genetic DNA Test is a sophisticated diagnostic tool designed to assess genetic factors that may contribute to neurological disorders. This test employs Next-Generation Sequencing (NGS) technology to analyze the SLC12A6 gene, which is critical for brain function and peripheral nerve health. Understanding your genetic predisposition can aid in early diagnosis and management of related conditions.
What the Test Measures
This test detects mutations or variations in the SLC12A6 gene that are associated with agenesis of the corpus callosum and peripheral neuropathy. By identifying these genetic markers, healthcare providers can better understand the underlying causes of neurological symptoms and tailor treatment accordingly.
Who Should Consider This Test
Individuals who may benefit from this test include:
- Those with a family history of neurological disorders.
- Patients exhibiting symptoms such as developmental delays, coordination issues, or sensory disturbances.
- Individuals with a known diagnosis of agenesis of the corpus callosum or peripheral neuropathy.
Benefits of Taking the Test
Taking the SLC12A6 Gene Agenesis of the Corpus Callosum with Peripheral Neuropathy NGS Genetic DNA Test offers several advantages:
- Early identification of genetic predispositions to neurological disorders.
- Informed decision-making regarding treatment and management options.
- Potential for personalized healthcare strategies based on genetic findings.
Understanding Your Results
Results from the SLC12A6 gene test will provide insights into any genetic variations detected. It is important to discuss these results with a healthcare professional who can explain their significance and recommend further steps based on your specific situation.
Test Pricing
| Test Name | Discount Price (KSh) | Regular Price (KSh) |
|---|---|---|
| SLC12A6 Gene Agenesis of the Corpus Callosum with Peripheral Neuropathy NGS Genetic DNA Test | 40,000 | 56,000 |
Branches and Booking
We have branches across all major cities in Kenya, including Nairobi, Mombasa, and Kisumu. Our team is ready to assist you with the SLC12A6 Gene Agenesis of the Corpus Callosum with Peripheral Neuropathy NGS Genetic DNA Test. To book your test, please call or WhatsApp us at +254711564616.
Turnaround Time
The expected turnaround time for this test is between 25 days to 4 weeks, depending on the complexity of the analysis.
Sample Type
The test requires either blood samples or extracted DNA. Alternatively, a single drop of blood on an FTA card is also acceptable.
Pre-Test Instructions
Before undergoing the SLC12A6 Gene Agenesis of the Corpus Callosum with Peripheral Neuropathy NGS Genetic DNA Test, patients are advised to have a genetic counseling session to outline the clinical history and draw a pedigree chart of family members affected by this condition.
